GENE ONLINE|News &
Opinion
Blog

Novavax
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Strategic Collaboration Between SK Bioscience and Novavax: Accelerating Vaccine Research and Global Expansion
2023-08-24
Novavax, Takeda, and BMS To Cut Employees This Year
2023-05-10
Novavax Begins Phase 2 For COVID-19/Influenza Combination And Stand-Alone Flu Shots
2023-01-03
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
2022-10-12
Novavax Requires Extra Warnings One Day After Receiving Emergency Use Authorization
2022-07-18
FDA Panel Recommends Novavax To Be Fourth Authorized COVID-19 Vaccine in America
2022-06-08
Was Novavax’s Vaccine Rollout Smooth?
2022-03-16
SK Bioscience Files for Approval of Novavax’s COVID-19 Vaccine
2021-11-17
Takeda to Supply 150 Million Doses of Novavax COVID-19 Vaccine to Japan
2021-09-08
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
Novavax’s Protein Subunit Vaccine Shows 89.3% Efficacy in Phase 3 UK Trial
2021-01-29
Philippines Signs Second Vaccine Deal to Procure 30 Million Doses of Novavax’s Covovax
2021-01-12
Novavax’s COVID-19 Vaccine is Safe and Immunogenic in Early Trial
2020-08-06
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top